\BOOKMARK [1][-]{section.0.1}{Patient haplotypes}{}% 1
\BOOKMARK [1][-]{section.0.2}{Drug annotations}{}% 2
\BOOKMARK [1][-]{section.0.3}{Haplotype Guidelines}{}% 3
\BOOKMARK [2][-]{subsection.0.3.1}{ tegafur }{section.0.3}% 4
\BOOKMARK [2][-]{subsection.0.3.2}{ capecitabine }{section.0.3}% 5
\BOOKMARK [2][-]{subsection.0.3.3}{ fluorouracil }{section.0.3}% 6
\BOOKMARK [2][-]{subsection.0.3.4}{ ivacaftor }{section.0.3}% 7
\BOOKMARK [2][-]{subsection.0.3.5}{ peginterferon alfa-2b }{section.0.3}% 8
\BOOKMARK [2][-]{subsection.0.3.6}{ phenprocoumon }{section.0.3}% 9
\BOOKMARK [2][-]{subsection.0.3.7}{ venlafaxine }{section.0.3}% 10
\BOOKMARK [2][-]{subsection.0.3.8}{ acenocoumarol }{section.0.3}% 11
\BOOKMARK [2][-]{subsection.0.3.9}{ irinotecan }{section.0.3}% 12
\BOOKMARK [2][-]{subsection.0.3.10}{ peginterferon alfa-2a }{section.0.3}% 13
\BOOKMARK [2][-]{subsection.0.3.11}{ warfarin }{section.0.3}% 14
\BOOKMARK [2][-]{subsection.0.3.12}{ atazanavir }{section.0.3}% 15
\BOOKMARK [2][-]{subsection.0.3.13}{ mercaptopurine }{section.0.3}% 16
\BOOKMARK [2][-]{subsection.0.3.14}{ tolbutamide }{section.0.3}% 17
\BOOKMARK [2][-]{subsection.0.3.15}{ tacrolimus }{section.0.3}% 18
\BOOKMARK [1][-]{section.0.4}{Clinical Annotations}{}% 19
\BOOKMARK [2][-]{subsection.0.4.1}{ tegafur }{section.0.4}% 20
\BOOKMARK [2][-]{subsection.0.4.2}{ capecitabine }{section.0.4}% 21
\BOOKMARK [2][-]{subsection.0.4.3}{ fluorouracil }{section.0.4}% 22
\BOOKMARK [2][-]{subsection.0.4.4}{ rifampin }{section.0.4}% 23
\BOOKMARK [2][-]{subsection.0.4.5}{ celecoxib }{section.0.4}% 24
\BOOKMARK [2][-]{subsection.0.4.6}{ cyclosporine }{section.0.4}% 25
\BOOKMARK [2][-]{subsection.0.4.7}{ ivacaftor }{section.0.4}% 26
\BOOKMARK [2][-]{subsection.0.4.8}{ nevirapine }{section.0.4}% 27
\BOOKMARK [2][-]{subsection.0.4.9}{ phenprocoumon }{section.0.4}% 28
\BOOKMARK [2][-]{subsection.0.4.10}{ Pyrimidine analogues }{section.0.4}% 29
\BOOKMARK [2][-]{subsection.0.4.11}{ antiepileptics }{section.0.4}% 30
\BOOKMARK [2][-]{subsection.0.4.12}{ efavirenz }{section.0.4}% 31
\BOOKMARK [2][-]{subsection.0.4.13}{ acenocoumarol }{section.0.4}% 32
\BOOKMARK [2][-]{subsection.0.4.14}{ rosiglitazone }{section.0.4}% 33
\BOOKMARK [2][-]{subsection.0.4.15}{ phenytoin }{section.0.4}% 34
\BOOKMARK [2][-]{subsection.0.4.16}{ lorazepam }{section.0.4}% 35
\BOOKMARK [2][-]{subsection.0.4.17}{ carbamazepine }{section.0.4}% 36
\BOOKMARK [2][-]{subsection.0.4.18}{ lamotrigine }{section.0.4}% 37
\BOOKMARK [2][-]{subsection.0.4.19}{ isoniazid }{section.0.4}% 38
\BOOKMARK [2][-]{subsection.0.4.20}{ warfarin }{section.0.4}% 39
\BOOKMARK [2][-]{subsection.0.4.21}{ ethambutol }{section.0.4}% 40
\BOOKMARK [2][-]{subsection.0.4.22}{ methadone }{section.0.4}% 41
\BOOKMARK [1][-]{section.0.5}{Appendix 1: Top 3 haplotypes per gene}{}% 42
\BOOKMARK [1][-]{section.0.6}{Appendix 3: Low level annotations}{}% 43
\BOOKMARK [2][-]{subsection.0.6.1}{ Antivirals for treatment of HIV infections, combinations }{section.0.6}% 44
\BOOKMARK [2][-]{subsection.0.6.2}{ Platinum compounds }{section.0.6}% 45
\BOOKMARK [2][-]{subsection.0.6.3}{ antipsychotics }{section.0.6}% 46
\BOOKMARK [2][-]{subsection.0.6.4}{ Analgesics }{section.0.6}% 47
\BOOKMARK [2][-]{subsection.0.6.5}{ daunorubicin }{section.0.6}% 48
\BOOKMARK [2][-]{subsection.0.6.6}{ escitalopram }{section.0.6}% 49
\BOOKMARK [2][-]{subsection.0.6.7}{ tramadol }{section.0.6}% 50
\BOOKMARK [2][-]{subsection.0.6.8}{ vitamin e }{section.0.6}% 51
\BOOKMARK [2][-]{subsection.0.6.9}{ Beta Blocking Agents }{section.0.6}% 52
\BOOKMARK [2][-]{subsection.0.6.10}{ anthracyclines and related substances }{section.0.6}% 53
\BOOKMARK [2][-]{subsection.0.6.11}{ docetaxel }{section.0.6}% 54
\BOOKMARK [2][-]{subsection.0.6.12}{ midazolam }{section.0.6}% 55
\BOOKMARK [2][-]{subsection.0.6.13}{ tegafur }{section.0.6}% 56
\BOOKMARK [2][-]{subsection.0.6.14}{ tamoxifen }{section.0.6}% 57
\BOOKMARK [2][-]{subsection.0.6.15}{ capecitabine }{section.0.6}% 58
\BOOKMARK [2][-]{subsection.0.6.16}{ fluorouracil }{section.0.6}% 59
\BOOKMARK [2][-]{subsection.0.6.17}{ gemcitabine }{section.0.6}% 60
\BOOKMARK [2][-]{subsection.0.6.18}{ Opium alkaloids and derivatives }{section.0.6}% 61
\BOOKMARK [2][-]{subsection.0.6.19}{ benazepril }{section.0.6}% 62
\BOOKMARK [2][-]{subsection.0.6.20}{ repaglinide }{section.0.6}% 63
\BOOKMARK [2][-]{subsection.0.6.21}{ etoposide }{section.0.6}% 64
\BOOKMARK [2][-]{subsection.0.6.22}{ rifampin }{section.0.6}% 65
\BOOKMARK [2][-]{subsection.0.6.23}{ diuretics }{section.0.6}% 66
\BOOKMARK [2][-]{subsection.0.6.24}{ paclitaxel }{section.0.6}% 67
\BOOKMARK [2][-]{subsection.0.6.25}{ cyclosporine }{section.0.6}% 68
\BOOKMARK [2][-]{subsection.0.6.26}{ losartan }{section.0.6}% 69
\BOOKMARK [2][-]{subsection.0.6.27}{ raloxifene }{section.0.6}% 70
\BOOKMARK [2][-]{subsection.0.6.28}{ Ace Inhibitors, Plain }{section.0.6}% 71
\BOOKMARK [2][-]{subsection.0.6.29}{ nicotine }{section.0.6}% 72
\BOOKMARK [2][-]{subsection.0.6.30}{ nevirapine }{section.0.6}% 73
\BOOKMARK [2][-]{subsection.0.6.31}{ imatinib }{section.0.6}% 74
\BOOKMARK [2][-]{subsection.0.6.32}{ peginterferon alfa-2b }{section.0.6}% 75
\BOOKMARK [2][-]{subsection.0.6.33}{ methotrexate }{section.0.6}% 76
\BOOKMARK [2][-]{subsection.0.6.34}{ cotinine }{section.0.6}% 77
\BOOKMARK [2][-]{subsection.0.6.35}{ clozapine }{section.0.6}% 78
\BOOKMARK [2][-]{subsection.0.6.36}{ propofol }{section.0.6}% 79
\BOOKMARK [2][-]{subsection.0.6.37}{ pravastatin }{section.0.6}% 80
\BOOKMARK [2][-]{subsection.0.6.38}{ atenolol }{section.0.6}% 81
\BOOKMARK [2][-]{subsection.0.6.39}{ sulfonamides, urea derivatives }{section.0.6}% 82
\BOOKMARK [2][-]{subsection.0.6.40}{ hmg coa reductase inhibitors }{section.0.6}% 83
\BOOKMARK [2][-]{subsection.0.6.41}{ Pyrimidine analogues }{section.0.6}% 84
\BOOKMARK [2][-]{subsection.0.6.42}{ gefitinib }{section.0.6}% 85
\BOOKMARK [2][-]{subsection.0.6.43}{ ranibizumab }{section.0.6}% 86
\BOOKMARK [2][-]{subsection.0.6.44}{ ethanol }{section.0.6}% 87
\BOOKMARK [2][-]{subsection.0.6.45}{ venlafaxine }{section.0.6}% 88
\BOOKMARK [2][-]{subsection.0.6.46}{ Antiinflammatory agents, non-steroids }{section.0.6}% 89
\BOOKMARK [2][-]{subsection.0.6.47}{ antiepileptics }{section.0.6}% 90
\BOOKMARK [2][-]{subsection.0.6.48}{ valproic acid }{section.0.6}% 91
\BOOKMARK [2][-]{subsection.0.6.49}{ efavirenz }{section.0.6}% 92
\BOOKMARK [2][-]{subsection.0.6.50}{ ondansetron }{section.0.6}% 93
\BOOKMARK [2][-]{subsection.0.6.51}{ bupropion }{section.0.6}% 94
\BOOKMARK [2][-]{subsection.0.6.52}{ deferasirox }{section.0.6}% 95
\BOOKMARK [2][-]{subsection.0.6.53}{ cyclophosphamide }{section.0.6}% 96
\BOOKMARK [2][-]{subsection.0.6.54}{ sunitinib }{section.0.6}% 97
\BOOKMARK [2][-]{subsection.0.6.55}{ dobutamine }{section.0.6}% 98
\BOOKMARK [2][-]{subsection.0.6.56}{ acenocoumarol }{section.0.6}% 99
\BOOKMARK [2][-]{subsection.0.6.57}{ rosiglitazone }{section.0.6}% 100
\BOOKMARK [2][-]{subsection.0.6.58}{ busulfan }{section.0.6}% 101
\BOOKMARK [2][-]{subsection.0.6.59}{ bevacizumab }{section.0.6}% 102
\BOOKMARK [2][-]{subsection.0.6.60}{ Drugs For Treatment Of Tuberculosis }{section.0.6}% 103
\BOOKMARK [2][-]{subsection.0.6.61}{ coumarin }{section.0.6}% 104
\BOOKMARK [2][-]{subsection.0.6.62}{ iloperidone }{section.0.6}% 105
\BOOKMARK [2][-]{subsection.0.6.63}{ fexofenadine }{section.0.6}% 106
\BOOKMARK [2][-]{subsection.0.6.64}{ risperidone }{section.0.6}% 107
\BOOKMARK [2][-]{subsection.0.6.65}{ carbamazepine }{section.0.6}% 108
\BOOKMARK [2][-]{subsection.0.6.66}{ amlodipine }{section.0.6}% 109
\BOOKMARK [2][-]{subsection.0.6.67}{ carvedilol }{section.0.6}% 110
\BOOKMARK [2][-]{subsection.0.6.68}{ ticagrelor }{section.0.6}% 111
\BOOKMARK [2][-]{subsection.0.6.69}{ opioids }{section.0.6}% 112
\BOOKMARK [2][-]{subsection.0.6.70}{ enalapril }{section.0.6}% 113
\BOOKMARK [2][-]{subsection.0.6.71}{ sildenafil }{section.0.6}% 114
\BOOKMARK [2][-]{subsection.0.6.72}{ catecholamines }{section.0.6}% 115
\BOOKMARK [2][-]{subsection.0.6.73}{ doxorubicin }{section.0.6}% 116
\BOOKMARK [2][-]{subsection.0.6.74}{ irinotecan }{section.0.6}% 117
\BOOKMARK [2][-]{subsection.0.6.75}{ metoprolol }{section.0.6}% 118
\BOOKMARK [2][-]{subsection.0.6.76}{ peginterferon alfa-2a }{section.0.6}% 119
\BOOKMARK [2][-]{subsection.0.6.77}{ nifedipine }{section.0.6}% 120
\BOOKMARK [2][-]{subsection.0.6.78}{ haloperidol }{section.0.6}% 121
\BOOKMARK [2][-]{subsection.0.6.79}{ anastrozole }{section.0.6}% 122
\BOOKMARK [2][-]{subsection.0.6.80}{ cytarabine }{section.0.6}% 123
\BOOKMARK [2][-]{subsection.0.6.81}{ quetiapine }{section.0.6}% 124
\BOOKMARK [2][-]{subsection.0.6.82}{ irbesartan }{section.0.6}% 125
\BOOKMARK [2][-]{subsection.0.6.83}{ atorvastatin }{section.0.6}% 126
\BOOKMARK [2][-]{subsection.0.6.84}{ erlotinib }{section.0.6}% 127
\BOOKMARK [2][-]{subsection.0.6.85}{ isoniazid }{section.0.6}% 128
\BOOKMARK [2][-]{subsection.0.6.86}{ warfarin }{section.0.6}% 129
\BOOKMARK [2][-]{subsection.0.6.87}{ ethambutol }{section.0.6}% 130
\BOOKMARK [2][-]{subsection.0.6.88}{ acetaminophen }{section.0.6}% 131
\BOOKMARK [2][-]{subsection.0.6.89}{ lamivudine }{section.0.6}% 132
\BOOKMARK [2][-]{subsection.0.6.90}{ simvastatin }{section.0.6}% 133
\BOOKMARK [2][-]{subsection.0.6.91}{ atazanavir }{section.0.6}% 134
\BOOKMARK [2][-]{subsection.0.6.92}{ mercaptopurine }{section.0.6}% 135
\BOOKMARK [2][-]{subsection.0.6.93}{ ritonavir }{section.0.6}% 136
\BOOKMARK [2][-]{subsection.0.6.94}{ fluvastatin }{section.0.6}% 137
\BOOKMARK [2][-]{subsection.0.6.95}{ verapamil }{section.0.6}% 138
\BOOKMARK [2][-]{subsection.0.6.96}{ tolbutamide }{section.0.6}% 139
\BOOKMARK [2][-]{subsection.0.6.97}{ Dabigatran }{section.0.6}% 140
\BOOKMARK [2][-]{subsection.0.6.98}{ morphine }{section.0.6}% 141
\BOOKMARK [2][-]{subsection.0.6.99}{ thalidomide }{section.0.6}% 142
\BOOKMARK [2][-]{subsection.0.6.100}{ codeine }{section.0.6}% 143
\BOOKMARK [2][-]{subsection.0.6.101}{ tacrolimus }{section.0.6}% 144
\BOOKMARK [2][-]{subsection.0.6.102}{ sorafenib }{section.0.6}% 145
\BOOKMARK [2][-]{subsection.0.6.103}{ zidovudine }{section.0.6}% 146
\BOOKMARK [2][-]{subsection.0.6.104}{ methadone }{section.0.6}% 147
\BOOKMARK [2][-]{subsection.0.6.105}{ clopidogrel }{section.0.6}% 148
